These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28894400)

  • 61. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.
    Krueger TS; Clark EA; Nix DE
    Diagn Microbiol Infect Dis; 2001; 41(1-2):71-8. PubMed ID: 11687317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
    Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
    Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.
    Yilmaz M; Celik AF; Mert A
    J Infect Chemother; 2007 Apr; 13(2):122-3. PubMed ID: 17458682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections.
    Tekçe YT; Erbay A; Cabadak H; Sen S
    J Chemother; 2012 Jun; 24(3):150-4. PubMed ID: 22759759
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
    Al-Jasser AM
    Ann Clin Microbiol Antimicrob; 2006 Sep; 5():23. PubMed ID: 16978420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative activity of antimicrobials against
    Spierer O; Miller D; O'Brien TP
    Br J Ophthalmol; 2018 May; 102(5):708-712. PubMed ID: 29459431
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Su BA; Chen CC; Chen HJ; Lai HY; Tsai CH; Lai CC; Tang HJ; Chao CM
    Front Microbiol; 2023; 14():1186669. PubMed ID: 37408643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genotypic Diversity, Antibiotic Resistance, and Virulence Phenotypes of
    Yinsai O; Deeudom M; Duangsonk K
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830320
    [No Abstract]   [Full Text] [Related]  

  • 70. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
    Köseoğlu O; Sener B; Gür D
    Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial Susceptibility, Minimum Inhibitory Concentrations, and Clinical Profiles of
    Ho MC; Hsiao CH; Sun MH; Hwang YS; Lai CC; Wu WC; Chen KJ
    Microorganisms; 2021 Aug; 9(9):. PubMed ID: 34576735
    [No Abstract]   [Full Text] [Related]  

  • 72. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medical Management of Endocarditis Caused by
    Shah S; King M; Rose L
    J Pharm Pract; 2019 Dec; 32(6):683-686. PubMed ID: 29575970
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distribution of Class I Integron and
    Malekan M; Tabaraie B; Akhoundtabar L; Afrough P; Behrouzi A
    Avicenna J Med Biotechnol; 2017; 9(3):138-141. PubMed ID: 28706609
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial therapy for Stenotrophomonas maltophilia infections.
    Nicodemo AC; Paez JI
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):229-37. PubMed ID: 17334747
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular epidemiology, genetic diversity, antibiotic resistance and pathogenicity of
    Wang L; Wang Y; Ye K; Qiu X; Zhao Q; Ye L; Yang J
    Front Microbiol; 2024; 15():1424241. PubMed ID: 38946894
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A review of 11 years of Stenotrophomonas maltophilia blood isolates at a tertiary care institute in Canada.
    Naidu P; Smith S
    Can J Infect Dis Med Microbiol; 2012; 23(4):165-9. PubMed ID: 24294268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen
    Paprocka P; Mańkowska A; Skłodowski K; Król G; Wollny T; Lesiak A; Głuszek K; Savage PB; Durnaś B; Bucki R
    Pathogens; 2022 May; 11(6):. PubMed ID: 35745475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance.
    Goncalves-Vidigal P; Grosse-Onnebrink J; Mellies U; Buer J; Rath PM; Steinmann J
    J Cyst Fibros; 2011 Dec; 10(6):422-7. PubMed ID: 21763218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.